Acadia Pharmaceuticals Inc

XNAS: ACAD

Strong Performer, Under Radar

Download real time

16.79 -0.39 (-2.27%)

4.0M XNAS Volume

High volume today

XNAS 21 Mar, 2025 5:30 PM (EDT)

2,800.4

Market Cap

High in industry

0.2

Beta 1Year

Very Low volatility

Acadia Pharmaceuticals Inc - ACAD - stock price prediction, stock price target, analyst ratings from 20 analysts

Acadia Pharmaceuticals Inc has a share price target of US$ 25, revenue growth forecast of 10.9%, and profit growth estimate of -59.6% for FY25, based on top 20 analyst calls.

Forecaster Screeners